dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Betriu, Ángeles |
dc.contributor.author | López-Cano, Carolina |
dc.contributor.author | Hernández, Marta |
dc.contributor.author | Fernández, Elvira |
dc.contributor.author | Purroy, Francisco |
dc.contributor.author | Hernández Pascual, Cristina |
dc.contributor.author | Simó Canonge, Rafael |
dc.contributor.author | Sánchez, Enric |
dc.date.accessioned | 2021-04-12T07:00:45Z |
dc.date.available | 2021-04-12T07:00:45Z |
dc.date.issued | 2019-11-15 |
dc.identifier.citation | Sánchez E, Betriu À, López-Cano C, Hernández M, Fernández E, Purroy F, et al. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project. Cardiovasc Diabetol. 2019 Nov 15;18(1):154. |
dc.identifier.issn | 1475-2840 |
dc.identifier.uri | https://hdl.handle.net/11351/5835 |
dc.description | Factors de risc cardiovascular; Malaltia ateromàtica subclínica; Prediabetes |
dc.description.sponsorship | This work was partially supported by grants from the Diputació de Lleida and the Generalitat de Catalunya (2017SGR696 and SLT0021600250) and Menarini Spain S.A. CIBER de Diabetes y Enfermedades Metabólicas Asociadas and CIBER de Enfermedades Respiratorias are initiatives of the Instituto de Salud Carlos III. |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Cardiovascular Diabetology;18(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Prediabetis |
dc.subject | Aterosclerosi |
dc.subject.mesh | Prediabetic State |
dc.subject.mesh | Atherosclerosis |
dc.title | Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s12933-019-0962-6 |
dc.subject.decs | estado prediabético |
dc.subject.decs | aterosclerosis |
dc.relation.publishversion | https://cardiab.biomedcentral.com/articles/10.1186/s12933-019-0962-6 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sánchez E, López-Cano C, Hernández M] Endocrinology and Nutrition Department, University Hospital Arnau de Vilanova, Obesity, Diabetes and Metabolism (ODIM) research Group, IRBLleida, University of Lleida, Lleida, Spain. [Betriu À, Fernández E] Vascular and Renal Translational Research Group, IRBLleida, RedinRen-ISCIII, Lleida, Spain. [Purroy F] Stroke Unit, University Hospital Arnau de Vilanova, Clinical Neurosciences Group. IRBLleida, University of Lleida, Lleida, Spain. [Hernández C, Simó R] Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain |
dc.identifier.pmid | 31729979 |
dc.identifier.wos | 000497385400001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR696 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |